Skip to main content

Table 4 Multivariate analysis of prognostic factors for time to progression

From: Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study

Variables HR (95% CI) P value
Tumor size 1.036 (0.939, 1.143) 0.480
Tumor number 1.464 (0.962, 2.230) 0.075
α-Fetoprotein level   
 > 400 ng/mL 1  
 ≤ 400 ng/ml 1.580 (0.949, 2.631) 0.079
Child–Pugh score   
A 1  
B 0.623 (0.370, 1.048) 0.074
BCLC stage   
A   
B 0.662 (0.398, 1.102) 0.113
Treatment method   
Early-RFA 1  
Late-RFA 0.397 (0.252, 0.625) 0.000
  1. HR: Hazard ratio; CI: Confidence interval; BCLC: Barcelona Clinic Liver Cancer; RFA: Radiofrequency ablation
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us

\